Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancerTomasz M Beer, Kristine M Eilers, Mark Garzotto, et al.The Journal of Molecular Diagnostics : JMD|January 14, 2011
Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimensRaji Pillai, Rebecca Deeter, C Ted Rigl, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2013
Cost-effectiveness of gene-expression profiling for tumor-site originJohn Hornberger, Irina Degtiar, Hialy Gutierrez, et al.Oncotarget|February 29, 2012
A gene expression profile test for the differential diagnosis of ovarian versus endometrial cancersAnita Lal, Rebecca Panos, Mira Marjanovic, et al.Diagnostic Pathology|March 19, 2013
A gene expression profile test to resolve head & neck squamous versus lung squamous cancersAnita Lal, Rebecca Panos, Mira Marjanovic, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomyTomasz M Beer, Anne Myrthue, Mark Garzotto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of originFederico A Monzon, Maureen Lyons-Weiler, Ljubomir J Buturovic, et al.Cancer Chemotherapy and Pharmacology|October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind M Javle, Christopher W Ryan, et al.Cancer|October 27, 2007
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxelTomasz M Beer, Christopher W Ryan, Peter M Venner, et al.Journal of Surgical Oncology|April 12, 2011
Unique patterns of metastases in common and rare types of malignancyStanley P L Leong, Eric K Nakakura, Raphael Pollock, et al.Pageof 3